Skip to main content
All lobbying filings

Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc. filed a Q1 report for Sarepta Therapeutics, Inc. on April 20, 2026.

Lobbying for Sarepta Therapeutics, Inc.

As filed: SAREPTA THERAPEUTICS, INC. for SAREPTA THERAPEUTICS, INC.

All filings by Sarepta Therapeutics, Inc. · Everything Sarepta Therapeutics, Inc. has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 20, 2026
Expenses
$270,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
California

Official filing document

 Lobbyists on this filing 1
  • MADISON SMITH Former member of Congress New on this filing
    Previously held: Staff Assistant, Rep. Jerry Lewis; Staff Assistant, Rep. Ken Calvert

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2

Duchenne Muscular Dystrophy and Rare Disease Patient Access to Treatments Newborn Screening for Rare Diseases

Scientific Innovation in Healthcare Gene Therapies Artificial Intelligence and Data Governance

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem